TAG:
laboratories
Innovative AP Reports Created by Path Group
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: Too often local pathology groups fail to react to intensified sales competition for the biopsy referrals of clinicians in their community. In Torrance, California, the 30 pathologists of Pathology, Inc. decided it was time to invest capital and resources into developing their…
Picking Winners and Losers For the Molecular Test Menu
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: In the 15 years it has operated a molecular diagnostics testing program, Beaumont Reference Laboratory (BRL) has learned important lessons on how to evaluate which specific molecular assays are ready for clinical introduction. It has also learned effective ways to anticipate …
Proteomic Tests Poised For Clinical Market
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the…
“August 22, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
In California, some physicians continue to seek illegal kickbacks from clinical laboratories. The problem is widespread enough that the FBI has conducted several “sting operations.” In a jury trial related to the long-running “Durascam” healthcare fraud investigation, a married pair of doctor…
New Federal Anti-kickback Investigation
By R. Lewis Dark | From the Volume XII No. 11 – August 1, 2005 Issue
POTENTIAL ANTI-KICKBACK VIOLATIONS in ancillary clinical service arrangements between referring physicians and providers like radiologists and laboratories continue to attract the interest of federal healthcare investigators. Right now, it appears radiology is a primary target. Last week, the Wa…
For Quest and LabCorp, The Story is “Molecular”
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecula…
Technology Can Now Enable “Card Swipe” for Draw Sites
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
COLLECTING SMALL AMOUNTS of money from patients for deductible, co-pay, and self-pay fees has always bedeviled laboratories. However, new technology holds the promise of solving this long-standing problem. BlueCross BlueShield of South Carolina (BCBC-SC) is currently offering a new …
Pinkus DermPath Earns ISO-9000 Certification
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: After learning about quality management systems at a recent Executive War College, the lab director at Pinkus Dermatopathology recognized how such techniques could be used in his lab to improve quality, reduce errors, and create a better working environment for both pathologi…
Molecular Diagnostics: How Beaumont Built A Successful Program
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key…
“August 1, 2005 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
Redwood City, California-based Genomic Health, Inc. is considering an initial public offering (IPO) to raise as much as $75 million. The company filed preliminary documents with the Securities and Exchange Commission (SEC) on July 15, 2005. In January 2004, Genomic H…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized